Janus Henderson Group PLC Veracyte, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 34,326 shares of VCYT stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,326
Previous 30,326
13.19%
Holding current value
$1.09 Million
Previous $1.03 Million
31.81%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding VCYT
# of Institutions
339Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$261 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$248 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$210 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$134 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$130 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.28B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...